Latest

psychopharmacology

Auditory Neuroscience Featured Neuroscience Psychology

·April 20, 2026·7 min read

SSRIs May Trigger Tinnitus

A new study identifies a specific serotonin circuit that triggers the auditory system, explaining why SSRIs can worsen tinnitus and offering a new target for treatment.

This shows an illustration of colorful, psychedelic neurons.

Featured Neuroscience Psychology

·April 8, 2026·8 min read

How Science Solved the Mystery of the Psychedelic High

A massive international study identifies a universal pattern of brain activity across psilocybin, LSD, DMT, and more. Researchers found that all major psychedelics dissolve brain network boundaries, triggering global "cross-talk."

Featured Neuroscience Psychology

·March 30, 2026·8 min read

Blocking NOX-1 Extends Ketamine’s Effectiveness for Depression

Researchers have identified the NOX-1 enzyme as the reason ketamine's antidepressant effects are short-lived. By blocking NOX-1, they extended the drug's benefits from days to weeks.

Featured Neuroscience Psychology

·March 25, 2026·8 min read

ADHD Medication May Shield Against Psychosis

A massive study of 700,000 people shows that ADHD medication in childhood does not increase the risk of psychosis. In fact, starting treatment before age 13 may help protect against schizophrenia in adulthood.

This shows a scale, a pill and mushrooms.

Featured Neuroscience Psychology

·March 18, 2026·9 min read

Psychedelics Match, But Don’t Beat, Traditional Antidepressants

New research reveals that the perceived advantage of psychedelics over antidepressants disappears when the "knowledge of treatment" factor is equalized.

This shows a head surrounded by mushrooms.

Featured Neuroscience Psychology

·March 6, 2026·6 min read

Healing Without the Hallucinations: The Next Generation of Psilocybin Therapy

Scientists have synthesized a new compound that delivers the benefits of magic mushrooms without the mind-altering side effects.

Featured Neuroscience Psychology

·March 4, 2026·8 min read

Psychedelics Remodel Myelin to Heal PTSD

New research reveals that psychedelics don't just rewire the brain—they physically repair the "neural insulation" needed to sustain long-term PTSD recovery.

Neuroscience

·February 28, 2026·7 min read

Ketamine Revolution: Study Redefines Depression Treatment

Pioneering research into ketamine has moved depression treatment away from slow-acting serotonin drugs toward rapid-acting glutamate therapy.

Featured Neuroscience Psychology

·February 23, 2026·5 min read

Moving Beyond Dopamine to Treat Schizophrenia

Dopamine isn't the whole story. A massive new review outlines the next generation of schizophrenia therapies that target the immune system, the gut, and cognitive receptors.

Featured Neuroscience Psychology

·February 22, 2026·7 min read

Could an “Exercise Pill” Help Treat Depression?

Exercise is medicine, but what if you can't take the dose? Scientists explore "exercise mimetics"—pills that trick your brain into thinking you've just finished a workout.

This shows a head with psychedelic images surrounding it, implying DMT's affect on resolving depression.

Featured Neuroscience Psychology

·February 17, 2026·9 min read

Single DMT Dose Provides Lasting Relief from Depression

A 25-minute "trip" for six months of relief? Researchers have found that the ayahuasca compound DMT provides a rapid, durable shield against depression.

Featured Neuroscience Psychology

·February 13, 2026·8 min read

Antidepressants May Safeguard Against Preterm Birth Risks

Does treating depression with antidepressants during pregnancy harm the baby? A massive new study reveals that while SSRIs increase gestational diabetes risk, they also protect against preterm birth.